Bandaram Pharma Pack
Ticker > Company >

Bandaram Pharma Pack share price

Bandaram Pharma Packtech Ltd.

BSE: 524602 SECTOR: Pharmaceuticals & Drugs  5235   3   0

46.20
0 0
BSE: 20 Dec 04:01 PM

Price Summary

Today's High

₹ 46.2

Today's Low

₹ 42

52 Week High

₹ 63.14

52 Week Low

₹ 28.31

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 55.44 Cr.

Enterprise Value

₹ 55.42 Cr.

No. of Shares

1.2 Cr.

P/E

473.85

P/B

4.51

Face Value

₹ 10

Div. Yield

0.22 %

Book Value (TTM)

₹  10.24

CASH

₹ 0.04 Cr.

DEBT

₹ 0.02 Cr.

Promoter Holding

75 %

EPS (TTM)

₹  0.1

Sales Growth

47.01%

ROE

1.68 %

ROCE

1.81%

Profit Growth

-37.12 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year47.01%
3 Year∞%
5 Year∞%

Profit Growth

1 Year-37.12%
3 Year82.33%
5 Year16.19%

ROE%

1 Year1.68%
3 Year1.8%
5 Year1.08%

ROCE %

1 Year1.81%
3 Year2.03%
5 Year1.22%

Debt/Equity

0.0014

Price to Cash Flow

-17.15

Interest Cover Ratio

0

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 75.00 0.00
Jun 2024 75.00 0.00
Mar 2024 75.00 0.00
Dec 2023 75.00 0.00
Sep 2023 75.00 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has significantly decreased its debt by 4.3875 Cr.
  • Company is virtually debt free.
  • The company has an efficient Cash Conversion Cycle of 67.2639 days.
  • Company has a healthy liquidity position with current ratio of 7.8536.
  • The company has a high promoter holding of 75%.

 Limitations

  • Company has a poor ROE of 1.79857325387084% over the past 3 years.
  • Company has a poor ROCE of 2.02706752007683% over the past 3 years
  • Company has contingent liabilities of 10.17 Cr.
  • Company has negative cash flow from operations of -3.2321.
  • The company has a low EBITDA margin of 0.7501% over the past 5 years.
  • The company is trading at a high PE of 473.85.
  • The company is trading at a high EV/EBITDA of 370.6.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Net Sales 3.54 5.7 1.5 2.72 3.17
Total Expenditure 3.48 5.63 1.53 2.97 2.83
Operating Profit 0.06 0.07 -0.03 -0.25 0.33
Other Income 0 0 0.03 0 0
Interest 0 0 0 0 0
Depreciation 0 0 0 0 0
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.05 0.07 -0.01 -0.25 0.33
Tax 0 0.02 0.01 0 0
Profit After Tax 0.05 0.05 -0.02 -0.25 0.33
Adjusted EPS (Rs) 0.05 0.04 -0.01 -0.21 0.28

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2018 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 0 0 0 10.09 14.84
Total Expenditure 1.12 0.01 0.01 9.82 14.67
Operating Profit -1.12 -0.01 -0.01 0.27 0.17
Other Income 0 0 0 0 0.03
Interest 0.01 0 0 0 0
Depreciation 0.03 0.02 0 0 0.02
Exceptional Items 0 0 0 0 0
Profit Before Tax -1.16 -0.03 -0.01 0.27 0.18
Tax 0 0 0 0.07 0.05
Net Profit -1.16 -0.03 -0.01 0.2 0.13
Adjusted EPS (Rs.) -1.77 -0.05 -0.01 0.24 0.11

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2018 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 2.28 2.28 3 3 12
Total Reserves -4.06 -4.6 -0.01 0.07 0.2
Borrowings 1.2 1.45 0 4.41 0.02
Other N/C liabilities 0.97 0.97 0 0 0
Current liabilities 0.95 1.16 0.01 0.79 1.21
Total Liabilities 1.34 1.26 3 8.27 13.43
Assets
Net Block 0.17 0.11 0 0.02 0.01
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0 0 0 2.51 3.91
Loans & Advances 0.39 0.39 0 0 0.01
Other N/C Assets 0 0 0 0 0
Current Assets 0.78 0.77 3 5.74 9.51
Total Assets 1.34 1.26 3 8.27 13.43
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2018 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations -1.16 -0.03 -0.01 0.27 0.17
Adjustment 0.03 0.02 0 0 0.02
Changes in Assets & Liabilities 0.15 0.01 2.93 -4.14 -3.38
Tax Paid 0 0 0 0 -0.04
Operating Cash Flow -0.98 0 2.91 -3.87 -3.23
Investing Cash Flow 0.42 0 -1.55 -2.53 -1.4
Financing Cash Flow 0 0 0.72 4.4 4.61
Net Cash Flow -0.56 0 2.08 -2 -0.02

Corporate Actions

Investors Details

PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
promoters 75.00 75.00 75.00 75.00 75.00
b.deepak reddy 15.00 15.00 15.00 15.00 39.38
b.premsai reddy 15.00 15.00 15.00 15.00 15.00
b.sathyavathi 15.00 15.00 15.00 15.00 15.00
l. lalanthika 3.75 3.75 3.75 3.75 3.75
m. seetharama reddy 0.94 0.94 0.94 0.94 0.94
m. sukumari 0.94 0.94 0.94 0.94 0.94
b.munirathnam reddy 24.38 24.38 24.38 24.38 -
PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
investors 25.00 25.00 25.00 25.00 25.00
sanivarapu jhansi 6.67 6.54 6.54 6.54 6.54
sanivarapu navya reddy 3.92 3.79 3.79 3.52 3.45
sapnaa 2.50 2.50 2.50 2.50 2.50
sreedar reddy g 3.33 3.33 3.33 3.33 3.33
suresh kumar surana 1.36 1.36 1.36 1.36 1.31

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Bandaram Pharma Packtech informs about disclosure 6 Dec, 12:33 PM Bandaram Pharma Packtech informs about disclosure 5 Dec, 5:18 PM Bandaram Pharma Packtech informs about disclosure 4 Dec, 5:16 PM Bandaram Pharma Packtech informs about compliance certificate 24 Oct, 4:59 PM Bandaram Pharma Pack - Quaterly Results 13 Aug, 4:18 PM Bandaram Pharma Pack - Quaterly Results 13 Aug, 4:18 PM Bandaram Pharma Packtech informs about certificate 10 Jul, 3:54 PM Bandaram Pharma Packtech informs about clarification 20 Mar, 2:32 PM Bandaram Pharma Pack - Quaterly Results 12 Feb, 5:09 PM Bandaram Pharma Pack - Quaterly Results 12 Feb, 5:09 PM Bandaram Pharma Pack - Quaterly Results 12 Feb, 5:09 PM Bandaram Pharma Packtech informs about disclosure 1 Feb, 5:23 PM Bandaram Pharma Packtech informs about postponement of board meeting 28 Oct, 3:37 PM Bandaram Pharma Packtech informs about newspaper clippings 14 Sep, 5:07 PM Bandaram Pharma Packtech informs about newspaper clippings 14 Aug, 2:24 PM Bandaram Pharma Packtech informs about outcome of right issue committee 23 Jun, 3:58 PM Bandaram Pharma Packtech informs about board meeting 6 May, 1:45 PM Bandaram Pharma Packtech informs about EGM notice 13 Feb, 4:45 PM Bandaram Pharma Packtech informs about board meeting 1 Feb, 12:11 PM Bandaram Pharma Packtech informs about board meeting 25 Jan, 11:41 AM Bandaram Pharma Pack - Quaterly Results 9 Nov, 6:18 PM Bandaram Pharma Pack - Quaterly Results 9 Nov, 6:18 PM Bandaram Pharma Packtech informs about board meeting 3 Nov, 10:01 AM Bandaram Pharma Pack - Quaterly Results 22 Jul, 5:43 PM Bandaram Pharma Pack - Quaterly Results 22 Jul, 5:43 PM Bandaram Pharma Pack - Quaterly Results 22 Jul, 5:43 PM Bandaram Pharma Packtech informs about board meeting 21 May, 10:23 AM Shiva Medicare informs about disclosure 4 Apr, 4:57 PM Shiva Medicare informs about disclosures 4 Apr, 2:45 PM Shiva Medicare informs about outcome of board meeting 10 Mar, 3:08 PM Shiva Medicare informs about updates 25 Feb, 10:28 AM

Bandaram Pharma Pack Stock Price Analysis and Quick Research Report. Is Bandaram Pharma Pack an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Bandaram Pharma Pack and its performance over the period of time. Bandaram Pharma Pack stock price today is Rs 46.2.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Bandaram Pharma Pack cash from the operating activity was Rs -3.2321 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Bandaram Pharma Pack has a Debt to Equity ratio of 0.0014 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Bandaram Pharma Pack , the EPS growth was -54.8142 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Bandaram Pharma Pack has OPM of 1.12540517955941 % which is a bad sign for profitability.
     
  • ROE: Bandaram Pharma Pack have a poor ROE of 1.681 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Bandaram Pharma Pack is Rs 46.2. One can use valuation calculators of ticker to know if Bandaram Pharma Pack share price is undervalued or overvalued.
Last Updated on:
Brief about Bandaram Pharma Pack
X